Xcout Intel
Femasys Inc.
Femasys Inc. is a medical technology company headquartered in Suwanee, Georgia, focusing on women's health and specialized therapeutic and diagnostic solutions.
Subscribe to see Femasys Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Femasys Inc. at a glance
Femasys Inc. is a medical - instruments & supplies company headquartered in Suwanee, United States. It is publicly listed (FEMY) with a market capitalisation of $16.8M. Xcout tracks 34 named people at Femasys Inc., including Kathy Lee-Sepsick (President and Chief Executive Officer).
Femasys Inc. leadership
- Kathy Lee-SepsickPresident and Chief Executive Officer
- Daniel CurrieChief Operating Officer
- John CanningChief Operating Officer
- Dov ElefantChief Financial Officer
- Jeremy Alexander SiposChief Technology Officer
- Jeremy SiposChief Technology Officer
28 more named people on record for Femasys Inc., with roles, board committees and tenure — see the full roster →
Femasys Inc. funding rounds before its IPO
The most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $40M | — |
Financing after the IPO — public offerings and SEC Form D private placements — is not listed as a funding round.
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Femasys Inc. competitors
A few of Femasys Inc.'s closest competitors — see the full list of competitors and alternatives →
Trimedic is a Canadian company founded in 1986 that specializes in diagnostic testing, women's health, and family planning. The company provides medical devices, supplies, instruments, and over-the-counter products, as well as care for patients with acute and chronic diseases.
Materna Medical Inc. is a women's health innovation company headquartered in Mountain View, California, focused on developing solutions for pelvic health, including the Ellora product.
Guided Therapeutics, Inc. is a medical technology firm specializing in the creation of medical devices. Its primary focus is on bringing to market LuViva, an innovative device designed for the non-invasive detection of cervical cancer. This technology excels at identifying both cancerous and precancerous conditions of the cervix in a painless, non-invasive manner, directly at the point of care. LuViva operates by scanning the cervix with light and subsequently analyzing both the reflected and fluorescent light emitted. Established in 1992 and headquartered in Norcross, Georgia, the company was formerly known as SpectRx, Inc. until its rebranding to Guided Therapeutics, Inc. in February 2008.
Axena Health, Inc. is a women's health company dedicated to redefining the standard of care for pelvic health conditions through clinically proven, non-invasive therapeutic solutions.
Get Femasys Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Femasys Inc. in Xcout Intel
- 34 named people with titles, LinkedIn and board committees
- 2 funding rounds before the IPO with the investors in each, and who they co-invest with
- 3 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access